Jung-Chan Ra
Fortuna: 16 M $ al 30/06/2026
Fortuna: 16 M $ al 30/06/2026
Jung-Chan Ra currently works at Bio Star Korea Co., Ltd., as Chief Executive Officer & Director.
Dr. Ra also formerly worked at R Bio Co., Ltd., as Chief Executive Officer in 2011 and NATURECELL Co., Ltd., as Director in 2023.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NATURECELL CO., LTD. 1,61 % | 26/03/2026 | 1.034.630 ( 1,61 % ) | 16 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Bio Star Korea Co., Ltd.
Bio Star Korea Co., Ltd. BiotechnologyHealth Technology Engages in research and development in biotechnology | Director Ejecutivo | - |
| Empresas | Cargo | Fin |
|---|---|---|
| NATURECELL CO.,LTD. | Director Ejecutivo | 12/04/2023 |
| K STECMCELL CO LTD | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
R Bio Co., Ltd.
R Bio Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
NATURECELL Co., Ltd.
NATURECELL Co., Ltd. Beverages: Non-AlcoholicConsumer Non-Durables Manufactures and wholesales fermented food and health supplements products | Consumer Non-Durables |
Bio Star Korea Co., Ltd.
Bio Star Korea Co., Ltd. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.